AR067729A1 - SILDENAFIL ORODISPERSABLE COMPOSITION - Google Patents
SILDENAFIL ORODISPERSABLE COMPOSITIONInfo
- Publication number
- AR067729A1 AR067729A1 ARP080103280A AR067729A1 AR 067729 A1 AR067729 A1 AR 067729A1 AR P080103280 A ARP080103280 A AR P080103280A AR 067729 A1 AR067729 A1 AR 067729A1
- Authority
- AR
- Argentina
- Prior art keywords
- sildenafil
- orodispersable
- composition
- pharmaceutical form
- mammal
- Prior art date
Links
Abstract
Un proceso de obtencion de dicha forma farmacéutica y su uso en la preparacion de un medicamento util en el tratamiento de la disfuncion eréctil y en la estimulacion de la actividad sexual en un mamífero. Reivindicacion 1: Una forma farmacéutica de rápida desintegracion bucal de sabor agradable, caracterizada porque comprende una sal de sildenafil, un copolímero de ácido metacrílico y al menos un excipiente farmacéuticamente aceptable.A process of obtaining said pharmaceutical form and its use in the preparation of a medicament useful in the treatment of erectile dysfunction and in the stimulation of sexual activity in a mammal. Claim 1: A pharmaceutical form of rapid oral disintegration of pleasant taste, characterized in that it comprises a sildenafil salt, a copolymer of methacrylic acid and at least one pharmaceutically acceptable excipient.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CL2007002239A CL2007002239A1 (en) | 2007-08-01 | 2007-08-01 | Pharmaceutical dosage form comprising a salt of 5-methyl- (6s) -tetrahydrofolic acid and granules comprising: a defened prgestagen, a defined estrogen and microcrystalline cellulose; Preparation process; pharmaceutical preparation; useful for contraception femeneina. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR067729A1 true AR067729A1 (en) | 2009-10-21 |
Family
ID=51399045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080103280 AR067729A1 (en) | 2007-08-01 | 2008-07-30 | SILDENAFIL ORODISPERSABLE COMPOSITION |
Country Status (3)
Country | Link |
---|---|
AR (1) | AR067729A1 (en) |
CL (1) | CL2007002239A1 (en) |
PE (1) | PE20090508A1 (en) |
-
2007
- 2007-08-01 CL CL2007002239A patent/CL2007002239A1/en unknown
-
2008
- 2008-07-30 AR ARP080103280 patent/AR067729A1/en unknown
- 2008-07-30 PE PE2008001276A patent/PE20090508A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CL2007002239A1 (en) | 2008-01-11 |
PE20090508A1 (en) | 2009-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008131056A3 (en) | Sustained release monoeximic formulations of opioid and nonopioid analgesics | |
WO2008131057A3 (en) | Sustained release formulations of opioid and nonopioid analgesics | |
BR112013003677A2 (en) | use of pharmacologically active agent and pharmaceutical dosage form | |
EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
LU92692I2 (en) | IBRUTINIB, OR A SALT PHARMACEUTICALLY ACCEPTABLE THERETO | |
MX2013000001A (en) | Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration. | |
CO6160321A2 (en) | USE OF 2-6- (3-AMINO-PIPERIDIN-1-IL) -3-METIL-2,4-DIOXO-3,4-DIHIDRO-2H-PYRIMIDIN-1-ILMETIL-4-FLUORO-BENZONITRILE | |
MX347237B (en) | Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction. | |
MY161593A (en) | Oral formulations of cytidine analogs and methods of use thereof | |
ZA200802811B (en) | Therapy for the treatment of disease | |
AR075735A1 (en) | PHARMACEUTICAL COMPOSITIONS OF IMMEDIATE RELEASE THAT INCLUDE OXYCODONE AND NALOXONE. USE | |
CO6270217A2 (en) | GALENIC FORMULATIONS OF ALISQUIRENO AND VALSARTAN | |
PE20081106A1 (en) | CAPECITABIN PEDIATRIC TABLETS | |
ATE505203T1 (en) | PHARMACEUTICAL COMBINATION OF ALISKIREN AND VALSARTAN | |
ECSP078014A (en) | DOSAGE REGIME FOR PRASUGREL | |
MX2021002322A (en) | Novel methods. | |
RU2012136724A (en) | TREATMENT OR PREVENTION OF INFECTION | |
AR061233A1 (en) | FORMULATION OF PROLONGED LIBERATION OF NALTREXONA | |
WO2007133796A3 (en) | Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist | |
TNSN08385A1 (en) | Delayed-release glucocorticoid treatment of rheumatoid disease | |
JP2011500589A5 (en) | ||
EA200970022A1 (en) | COMBINED PREPARATIONS CONTAINING BIFEPRUNOX AND L-DOSP | |
NI201200008A (en) | OTAMIXABAN FOR THE TREATMENT OF OLD-AGED AND KIDNEY DISORDERS WITH NON-ST-ELEVATION MYOCARDIAL INFARCTION | |
MX348723B (en) | Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder. | |
AR067729A1 (en) | SILDENAFIL ORODISPERSABLE COMPOSITION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |